Trials / Sponsors / Rottapharm Biotech
Rottapharm Biotech
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Me Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer | Phase 1 / Phase 2 | 2021-11-23 |
| Completed | Intra-articular PVA Hydrogel in Knee Osteoarthritis Knee Osteoarthritis | N/A | 2019-10-01 |
| Completed | A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheu Rheumatoid Arthritis, DMARD-naive and Early Disease Patients | Phase 2 | 2017-10-05 |